Frontlight ResearchEarly access
CompletedPhase 3
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Key facts
- Who runs it
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Where
- China2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 3
- People taking part
- 1,165 people enrolled
- Started
- 16 Mar 2025
- Ended
- 23 Apr 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- SHR-2004 injection
- Enoxaparin sodium injection
- Enoxaparin sodium injection placebo
- SHR-2004 placebo
- Record updated
- 28 August 2026
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Understand the research procedures and methods, volunteer to participate in this trial, and sign the informed consent form in writing
- Planned elective schedule total knee arthroplasty (TKA) patients
- Men or women who are ≥ 18 years old and < 80 years old on the day of signing the informed consent form
Who cannot take part
- Malignant tumor within one year of the screening
- Myocardial infarction, transient ischemic attack or ischemic stroke occurred within 6 months of the screening
- Any medical history that may increase the risk of bleeding or any conditions that the investigator considers to increase the risk of bleeding
- History of drug abuse
- Unable to receive CT angiography of both lower limbs
- Pregnant or lactating women
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the study is to evaluate the efficacy and safety of SHR-2004 in preventing venous thromboembolism after elective unilateral total knee arthroplasty.
The 3 groups in the trial
- Group ATreatment being tested
Treatment: SHR-2004 injection, Enoxaparin sodium injection placebo, and SHR-2004 placebo
- Group BTreatment being tested
Treatment: SHR-2004 injection, Enoxaparin sodium injection placebo, and SHR-2004 placebo
- Group CExisting treatment, for comparison
Treatment: Enoxaparin sodium injection and SHR-2004 placebo
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Multicenter, Randomized, Double-blind, Active-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Arthroplasty
- Record updated
- 28 August 2026